Investor Presentation • May 27, 2021
Investor Presentation
Open in ViewerOpens in native device viewer


This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers, and is designed solely to offer information as part of the Company's explanations on its 2021 Q1 financial reports.
This presentation includes information regarding the Company's strategic plan for the years 2020-24 as well as proforma analysis. Accordingly, the presentation includes forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of the mentioned forward-looking information will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, a change in working assumptions or in the economic models and assumptions used by the consulting firm – that can not be estimated in advance and are not controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy. This presentation was drafted for the sake of convenience and needs to be reviewed along side with the Company's public reports, including 2021 Q1 Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.


Financial Results
Segment Breakdown
Investments
Appendix
Glossary



High growth and compelling returns

(1) As of May 23, 2021
(2) Based on yields in the general plans: #1 out of 5 in Policies (1991-2003), #2 out of 5 in Pension, & #3 out of 12 in Provident Funds
(3) As of December 31, 2020 with transitional measures (standard model)
(4) As of March 31, 2021



Strong performance and momentum for 2021


Comprehensive Profit NIS millions

Investments & interest rates
Insurance* (P&C, LTS, Health, Ad-120)
Core Fee Businesses (Agencies, Excellence, Gama)




(1) Including LAT restatement for 2018-19; 2020 figure is before dividend distribution
(2) Including approximately 230 NISm of Mehadrin shares as a dividend in kind
(3) Mid-term Target based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-30.9.20)
(4) Including 2020 share buy-back program 26 NISm plus cash dividend 380 NISm 2020 distributed during 2021 Q1




1 AUMs include Halman-Aldubi plus Halman's 46 NISb corporate fund
2 Before dividend distribution of 0.4 NISb in March for 2020
3 Includes approximately 230 NISm of Mehadrin shares as a dividend in kind
4 Post report date, the Company completed a share purchase of additional 50 NISm
Note: Mid-term Targets based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-
30.9.20). Actual performance will depend on financial markets, macroeconomic growth, industry trends, company performance and other variables

4





Acquisition of Halman-Aldubi Completed

3
| • Halman-Aldubi mid-sized Israeli investment house |
|
|---|---|
| Description | • Key activity is asset management with 23 NISb AUM, primarily in long-term savings |
| Rationale | • Positions the Phoenix as a leader in the growing long-term savings industry, in line with group strategy |
| • Achieves economies of scale together with existing provident and pension fund activities |
|
| • Significant cost and commercial synergies |
|
| • Acquisition was completed on February 28, 2021 at a price of 275 NISm |
|
| Transaction | • 45 NISm expected proceeds from divestment of New Pension Fund |
| • Long-term savings subsidiary expected to be merged into the Phoenix Excellence Pension & Provident company by the end of 2021 |
|
| • In addition, the acquisition included 46 NISb corporate portfolio managed under specific arrangement (not considered strategic asset) |


Priorities for next quarters



Segment Breakdown
Investments
Appendix
Glossary


Comprehensive Income Drivers (NISm)

Results




Continued strategic focus on riskadjusted returns and growth of high-ROE businesses

| 2021 Q1 | 2020 Q1 | 2020 | ||
|---|---|---|---|---|
| P&C | Expenses / Gross Earned Premiums | 4.5% | 4.7% | 5.1% |
| Health | Expenses / Gross Earned Premiums | 5.7% | 5.9% | 5.9% |
| Life | Expenses / AUM | 0.48% | 0.54% | 0.49% |
| Pension & Provident | Expenses / AUM | 0.23% | 0.29% | 0.23% |
1



| Solvency results, NISm | 2019 | 2020 | Change | Target | |
|---|---|---|---|---|---|
| SCR | (1) | 7,456 | 6,662 | -794 | |
| Tier 1 Capital | 8,767 | 9,440 | 673 | ||
| Tier 2 Capital | 3,540 | 3,331 | -209 | ||
| Total Capital | (2) | 12,307 | 12,771 | 464 | |
| Excess Capital | 4,851 | 6,109 | 1,258 | ||
| Solvency II Ratio | (3) | 165% | 192% | 27% | 150%-170% |
| Solvency II Ratio Without Transitional Measures* | 105% | 116% | 11% |
| Significant events that affected Solvency II Ratio | (1) Effect on SCR | (2) Effect on Capital | (3) Overall effect on Solvency Ratio |
|---|---|---|---|
| Positive investments returns | |||
| Studies (expenses and lapse) | |||
| Differed taxes adjustments | |||
| Changes in risk free interest rate |
|||
| Mass-lapse reinsurance | |||
| Dividend distribution | |||
| Annual decrease of TMTP | |||
| LAT regulation circular effect on TMTP |


Financial Results
Investments
Appendix
Glossary






| 1-3/2021 | 72 | 106 | - | - | 178 |
|---|---|---|---|---|---|
| 1-3/2020 | 33 | (267) | 11 | - | (223) |


previous year

(*) The underwriting earnings assume a real rate of return of 3%, investment income includes income from own (nostro) investments above or below a 3% real return



• Increase in Pension and Provident performance due to investment income



| 1-3/2021 | 157 | 124 | (5) | - | 276 |
|---|---|---|---|---|---|
| 1-3/2020 | 18 | (140) | (44) | (94) | (260) |



Results 10 Underwriting profit 4 Market impact 1-3/2021 100 (42) (48) 2 2 14 1-3/2020 94 (40) (41) (4) (5) 4
Growth in comprehensive income mainly from investments and Gmula (runoff product) profit









(*) Phoeniclass and other subsidiaries held by Phoenix Investments
(**) Forward-looking information, there is no certainty that Gama will complete the issuance process and become a public company



Financial Results
Segment Breakdown
Appendix
Glossary


Fixed-Rate GOV Bond (5+) CPI 3.6% USD/NIS TLV35 TLV125 S&P 500 GOV Bond Index (5-10) MSCI Dow Jones Corporate Bond Index )0.5%( 0.1% )20.0%( 3.2% 3.7% )21.0%( 7.0% )21.0%( 6.1% )20.9%( 5.8% )23.2%( 7.8% )5.0%( 0.5% )2.1%( )3.3%( )9.1%( 2.2% CPI / FX Stocks Bonds Local Global Local
Main Market Indices
Israeli and international market volatility Q1/20 and Q1/21



Q1/21 financial market recovery and low global interest rates generated improved returns
1 Refers to yields in the general plan
Q1/20 Q1/21


Financial Results
Segment Breakdown
Investments
Appendix
Glossary







Financial Results
Segment Breakdown
Investments
Appendix
Glossary



| AM | Asset Management; i.e. Excellence Nessuah |
|---|---|
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |


| MF | Management Fees; wages charged by a financial manager |
|---|---|
| Moody's | A credit risk rating agency |
| MSCI | Morgan Stanley Capital International Emerging Markets Index; measures the performance in equity markets, specifically in global emerging markets |
| Mutual Fund | Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type |
| Net Inflows | The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits |
| NIS | New Israeli Shekel |
| Non-Marketable Securities | Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt securities, limited partnerships, real estate investments and more |
| Nostro | The account in which a financial institution manages its own funds |
| OPEX | Operational Expenses |
| P&C | Property and Casualty insurance |
| PH | Phoenix holdings |
| PHI | Permanent Health Insurance |
| PI | Phoenix insurance |
| PLI | Professional Liability insurance |
| Reinsurance | A balancing risk strategy; one or more insurers that share the liability |
| Revenue | All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions |
| RFR | Risk Free Rates |
| ROE | Return On Equity; calculated by dividing net income over total equity |
| SME60 | "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange |
| Tel Bond 20 | Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 | Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 | Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 | An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 | An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 | An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP | Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance | Insurance coverage for employees' injuries or sickness |
| Yield Curve | A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |

Please contact us at: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.